Regeneron’s antibody cocktail seems to reduce levels of coronavirus ... also had greater benefits in terms of symptom alleviation. Infusion reactions were seen in 4 patients (2 on placebo ...

The phase 3 portion of the trial will test safety and efficacy of a single intravenous infusion ... is based on a cocktail of two antibodies that neutralise the virus. Shares in Regeneron were ...

Monoclonal antibody ... with Regeneron’s combination of casirivimab and imdevimab — the treatment which the FDA OK’d for shots. Previously, clinical trials had only studied IV infusion ...

have as many infusions to high-risk people as possible and decrease the burden to the health-care system,” she said at the briefing. The Lilly and Regeneron antibody treatments mimic proteins ...

Regeneron has leveraged its monoclonal antibody ... yet a windfall from sales of its covid antibody cocktail as well as continuing solid sales of Eylea and Dupixent still gave the firm more ...